Brotons C, Ariño D, Borrás I, Buitrago F, González M L, Kloppe P, Orozco D, Pepió J M, Rodríguez P, Rodríguez A I
Unidad de Investigación, EAP Sardenya, Equip d'Atenció Primària Sardenya, Barcelona, Spain.
Aten Primaria. 2006 Mar 31;37(5):295-8. doi: 10.1157/13086317.
To assess the efficacy of a comprehensive secondary prevention programme to reduce morbidity and mortality in patients who have suffered a cardiovascular (CV) event; to control CV risk factors and prophylactic treatment in order to prevent recurrence; and to improve the quality of life of patients with cardiovascular disease.
Randomised, pragmatic, open clinical trial in primary care.
A total of 42 primary care centres of 8 different areas in Spain.
Men and women below 86 years old, diagnosed with coronary disease and/or stroke and/or peripheral vascular disease in the preceding year, and who have no serious or terminal disease.
Primary care centres will be randomised to following usual care (control group), or to following a comprehensive programme of secondary prevention (intervention group).
Cardiovascular fatal events, cardiovascular non-fatal events, total mortality and health-related quality of life (SF-36).
评估一项综合二级预防计划在降低发生心血管（CV）事件患者的发病率和死亡率方面的疗效；控制心血管危险因素和预防性治疗以预防复发；并改善心血管疾病患者的生活质量。
在初级保健机构进行的随机、实用、开放性临床试验。
西班牙8个不同地区的42个初级保健中心。
年龄在86岁以下，前一年被诊断患有冠心病和/或中风和/或外周血管疾病，且无严重或晚期疾病的男性和女性。
初级保健中心将被随机分为接受常规护理（对照组）或接受综合二级预防计划（干预组）。
心血管死亡事件、心血管非致命事件、总死亡率和与健康相关的生活质量（SF-36）。
